Comparative analysis of the results of cyanoacrylate ablation and radiofrequency ablation in the treatment of venous insufficiency

dc.authoridDaylan, Ahmet/0000-0003-4424-2880
dc.contributor.authorDaylan, Ahmet
dc.contributor.authorIslamoglu, Fatih
dc.date.accessioned2023-03-22T19:47:17Z
dc.date.available2023-03-22T19:47:17Z
dc.date.issued2022
dc.departmentBelirleneceken_US
dc.description46th Annual VEITH Symposium -- NOV 19-23, 2019 -- New York, NYen_US
dc.description.abstractBackground: Varicose vein treatment has shifted to less invasive techniques owing to the complications associated with traditional treatment. The present study was designed to compare the effectiveness of cyanoacrylate ablation (CAA) with radiofrequency ablation (RFA). Methods: Patients who had undergone RFA vs CAA (634 vs 246 patients) to treat great saphenous vein (GSV) insufficiency during a 5-year period were included in the present study. The preoperative and postoperative CEAP (clinical, etiologic, anatomic, pathophysiologic) class, symptoms, recurrence, and Doppler ultrasound findings were compared. Results: All the veins in both groups were occluded at day 5. The 1-month closure rates were 97.3% and 98.7% for RFA and CAA, respectively. The overall postoperative closure rates at 5 years were 93.1% and 91.1% for RFA and CAA, respectively. The postoperative symptoms, CEAP class, and Doppler ultrasound findings were similar in both groups. The 5-year symptom-free survival rates were 73.5% and 72.0% in the RFA and CAA groups, respectively. The venous clinical severity scores had decreased from 5.9 +/- 1.2 to 0.9 +/- 0.8 and 5.8 +/- 0.9 to 0.8 +/- 0.6 in the RFA and CAA groups, respectively. The Aberdeen varicose vein questionnaire scores had decreased from 19.7 +/- 5.5 to 4.8 +/- 1.5 in the RFA group and from 18.9 +/- 5.8 to 4.9 +/- 1.4 in the CAA group. Conclusions: CAA seems to be the ideal treatment for GSV insufficiency because it is suitable for most patients and is nonthermal and nontumescent, with satisfactory results comparable to those with RFA. Long-term outcomes and cost analyses from larger series are required to confirm our findings.en_US
dc.description.sponsorshipVEITHen_US
dc.identifier.doi10.1016/j.jvsv.2021.09.001
dc.identifier.endpage+en_US
dc.identifier.issn2213-333X
dc.identifier.issue3en_US
dc.identifier.pmid34536569en_US
dc.identifier.scopus2-s2.0-85124130946en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage661en_US
dc.identifier.urihttps://doi.org/10.1016/j.jvsv.2021.09.001
dc.identifier.urihttps://hdl.handle.net/20.500.14034/581
dc.identifier.volume10en_US
dc.identifier.wosWOS:000792468600014en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.journalJournal Of Vascular Surgery-Venous And Lymphatic Disordersen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic venous insufficiencyen_US
dc.subjectCyanoacrylate ablationen_US
dc.subjectRadiofrequency ablationen_US
dc.subjectVaricose veinsen_US
dc.subjectGreat Saphenous-Veinen_US
dc.subjectFoam Sclerotherapyen_US
dc.subjectVaricose-Veinsen_US
dc.subjectTruncal Veinsen_US
dc.subjectAdhesiveen_US
dc.subjectEmbolizationen_US
dc.subjectCatheteren_US
dc.subjectClosureen_US
dc.subjectGlueen_US
dc.titleComparative analysis of the results of cyanoacrylate ablation and radiofrequency ablation in the treatment of venous insufficiencyen_US
dc.typeConference Objecten_US

Dosyalar